ELONVA 100 micrograms, solution for injection syringe, 0.5 ml
Active ingredients: Corifollitropin alfa
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELONVA 100 microgrammes, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre avec aiguille(s) de 0,5 ml
- Marketing authorisation holder
- ORGANON (HOLLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Apr 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66844562CIP73745901CIP133400937459013Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CORIFOLLITROPINE ALFAsolution | 100 µg · 0,5 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.